Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/sim.6169 http://scihub22266oqcxt.onion/10.1002/sim.6169 C4663989!4663989!24757049     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Stat+Med 2014 ; 33 (19): 3241-52 Nephropedia Template TP {{tp|p=24757049|t=2014. A Modest Proposal for Dropping Poor Arms in Clinical Trials |pdf=|usr=}}{{24757049}} gab.com Text A Modest Proposal for Dropping Poor Arms in Clinical Trials JO: Stat Med http://www.kidney.de/pget.php?&tw=1&pmid=24757049 #FOAvip This paper presents a simple procedure for clinical trials comparing several arms to control. Demand for streamlining the evaluation of new treatments has led to Phase III clinical trials with more arms than would have been used in the past. In such a setting, it is reasonable that some arms may not perform as well as an active control. We introduce a simple procedure that takes advantage of negative results in some comparisons to lessen the required strength of evidence for other comparisons. We evaluate properties analytically, and use them to support claims made about multi-arm multi-stage (MAMS) designs. Twit Text FOAVip A Modest Proposal for Dropping Poor Arms in Clinical Trials ????Stat Med http://www.kidney.de/pget.php?&tw=1&pmid=24757049 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24757049 #FOAvip English Wikipedia <ref>{{Cite pmid|24757049}}</ref> A Modest Proposal for Dropping Poor Arms in Clinical Trials #MMPMID24757049 Proschan MA; Dodd LE Stat Med 2014[Aug]; 33 (19): 3241-52 PMID24757049show ga This paper presents a simple procedure for clinical trials comparing several arms to control. Demand for streamlining the evaluation of new treatments has led to Phase III clinical trials with more arms than would have been used in the past. In such a setting, it is reasonable that some arms may not perform as well as an active control. We introduce a simple procedure that takes advantage of negative results in some comparisons to lessen the required strength of evidence for other comparisons. We evaluate properties analytically, and use them to support claims made about multi-arm multi-stage (MAMS) designs. äA Modest Proposal for Dropping Poor Arms in Clinical Trials (epmc).pdf DeepDyve Pubget Overpricing